ID

38172

Description

Nimotuzumab Plus Docetaxel and Capecitabine Versus Docetaxel and Capecitabine in the Treatment of Breast Cancer Patients; ODM derived from: https://clinicaltrials.gov/show/NCT01939054

Link

https://clinicaltrials.gov/show/NCT01939054

Keywords

Versions (1)
  1. 9/24/19 9/24/19 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

September 24, 2019

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Breast Cancer NCT01939054

English

Eligibility Breast Cancer NCT01939054

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. histological and immunohistochemistry (ihc) confirmed recurrent or metastatic triple-negative breast cancer .
Description

Triple Negative Breast Neoplasm Recurrent Immunohistochemistry | Triple Negative Breast Neoplasm metastatic Immunohistochemistry

Data type

boolean

Alias
UMLS CUI [1,1]
C3539878
UMLS CUI [1,2]
C2945760
UMLS CUI [1,3]
C0021044
UMLS CUI [2,1]
C3539878
UMLS CUI [2,2]
C1522484
UMLS CUI [2,3]
C0021044
2. previous chemotherapy should include anthracycline or taxane; no prior chemotherapy after metastasis.
Description

Prior Chemotherapy | Anthracyclines | taxane | Absence Prior Chemotherapy Post Neoplasm Metastasis

Data type

boolean

Alias
UMLS CUI [1]
C1514457
UMLS CUI [2]
C0282564
UMLS CUI [3]
C0215136
UMLS CUI [4,1]
C0332197
UMLS CUI [4,2]
C1514457
UMLS CUI [4,3]
C0687676
UMLS CUI [4,4]
C0027627
3. females with age between 18 and 70 years old
Description

Gender | Age

Data type

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2]
C0001779
4. ecog performance status 0 or 1.
Description

ECOG performance status

Data type

boolean

Alias
UMLS CUI [1]
C1520224
5. at least one measurable disease according to the response evaluation criteria in solid tumor (recist) by magnetic resonance imaging, or computed tomography; the target lesions is unresectable; the target lesions did not receive radiotherapy or relapse within the radiation field;
Description

Measurable Disease Quantity MRI | Measurable Disease Quantity CT | Target Lesion unresectable | Therapeutic radiology procedure Absent Target Lesion | Relapse Within Radiation Field

Data type

boolean

Alias
UMLS CUI [1,1]
C1513041
UMLS CUI [1,2]
C1265611
UMLS CUI [1,3]
C0024485
UMLS CUI [2,1]
C1513041
UMLS CUI [2,2]
C1265611
UMLS CUI [2,3]
C0040405
UMLS CUI [3,1]
C2986546
UMLS CUI [3,2]
C1519810
UMLS CUI [4,1]
C1522449
UMLS CUI [4,2]
C0332197
UMLS CUI [4,3]
C2986546
UMLS CUI [5,1]
C0035020
UMLS CUI [5,2]
C0332285
UMLS CUI [5,3]
C1882536
6. life expectancy ≥ 12 weeks.；
Description

Life Expectancy

Data type

boolean

Alias
UMLS CUI [1]
C0023671
7. wbc count ≥ 4 × 109 / l, neutrophils ≥ 1.5 × 109 / l, platelet count ≥ 100 × 109 / l, hemoglobin ≥ 6.21mmol / l (10 g / dl);
Description

White Blood Cell Count procedure | Neutrophil count | Platelet Count measurement | Hemoglobin measurement

Data type

boolean

Alias
UMLS CUI [1]
C0023508
UMLS CUI [2]
C0200633
UMLS CUI [3]
C0032181
UMLS CUI [4]
C0518015
8. total bilirubin (tbl)≤ 1.5 x uln (upper limit of normal reference values); ast and alt ≤ 2.5 x uln or ≤ 5 uln (liver metastasis);serum creatinine ≤ 1.5 x uln.
Description

Serum total bilirubin measurement | Aspartate aminotransferase measurement | Alanine aminotransferase measurement | Secondary malignant neoplasm of liver | Creatinine measurement, serum

Data type

boolean

Alias
UMLS CUI [1]
C1278039
UMLS CUI [2]
C0201899
UMLS CUI [3]
C0201836
UMLS CUI [4]
C0494165
UMLS CUI [5]
C0201976
9. before enrollment, patients have fully recovered from previous treatment-related toxicity;
Description

Toxicity Due to Prior Therapy | Patient recovered

Data type

boolean

Alias
UMLS CUI [1,1]
C0600688
UMLS CUI [1,2]
C0678226
UMLS CUI [1,3]
C1514463
UMLS CUI [2]
C1115804
10. subjects with fertility must accept effective contraceptive measures;
Description

Fertility Contraceptive methods

Data type

boolean

Alias
UMLS CUI [1,1]
C0015895
UMLS CUI [1,2]
C0700589
11. signed informed consent
Description

Informed Consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. previously treatment regimen including anti egfr monoclonal antibody;
Description

Prior Therapy | Anti-EGFR Monoclonal Antibody

Data type

boolean

Alias
UMLS CUI [1]
C1514463
UMLS CUI [2]
C4522190
2. receiving other anti-cancer medicine treatment during the study
Description

Pharmacotherapy Malignant Neoplasms

Data type

boolean

Alias
UMLS CUI [1,1]
C0013216
UMLS CUI [1,2]
C0006826
3. participate in other clinical trials within 4 weeks in this group;
Description

Study Subject Participation Status

Data type

boolean

Alias
UMLS CUI [1]
C2348568
4. accepted taxane treatment in 1 year;
Description

taxane

Data type

boolean

Alias
UMLS CUI [1]
C0215136
5. presence of neurological symptoms due to brain metastasis, patients receiving steroidal anti-edema drugs therapy;
Description

Neurologic Symptoms Due to Metastatic malignant neoplasm to brain | Steroid therapy Edema

Data type

boolean

Alias
UMLS CUI [1,1]
C0235031
UMLS CUI [1,2]
C0678226
UMLS CUI [1,3]
C0220650
UMLS CUI [2,1]
C0149783
UMLS CUI [2,2]
C0013604
6. patients having a history of clinically significant symptomatic angina, arrhythmia or congestive heart failure without control;
Description

Angina Pectoris Symptomatic Uncontrolled | Cardiac Arrhythmia Uncontrolled | Congestive heart failure Uncontrolled

Data type

boolean

Alias
UMLS CUI [1,1]
C0002962
UMLS CUI [1,2]
C0231220
UMLS CUI [1,3]
C0205318
UMLS CUI [2,1]
C0003811
UMLS CUI [2,2]
C0205318
UMLS CUI [3,1]
C0018802
UMLS CUI [3,2]
C0205318
7. diagnosed with severe interstitial pneumonitis or pulmonary fibrosis by chest ct;
Description

Interstitial Pneumonia Severe Chest CT | Pulmonary Fibrosis Severe Chest CT

Data type

boolean

Alias
UMLS CUI [1,1]
C0206061
UMLS CUI [1,2]
C0205082
UMLS CUI [1,3]
C0202823
UMLS CUI [2,1]
C0034069
UMLS CUI [2,2]
C0205082
UMLS CUI [2,3]
C0202823
8. pleural effusion, ascites require to be drained;
Description

Pleural effusion disorder | Ascites Requirement Drainage

Data type

boolean

Alias
UMLS CUI [1]
C0032227
UMLS CUI [2,1]
C0003962
UMLS CUI [2,2]
C1514873
UMLS CUI [2,3]
C0013103
9. adverse drug addiction and drug abuse, long-term alcoholics, as well as aids patients; patients with severe or uncontrolled complications, such as infection requiring systemic therapy, fever (≥ 38 ℃), diabetes or hypertension can not be controlled by medicine, other complications may interfere with drug therapy;
Description

Drug Dependence | Drug abuse | Alcoholics Long-term | AIDS | Complications Severe | Complications Uncontrolled | Communicable Disease Requirement Systemic therapy | Fever Uncontrolled | Diabetes Mellitus Uncontrolled | Hypertensive disease Uncontrolled | Complications Interfere with Pharmacotherapy

Data type

boolean

Alias
UMLS CUI [1]
C1510472
UMLS CUI [2]
C0013146
UMLS CUI [3,1]
C0687725
UMLS CUI [3,2]
C0443252
UMLS CUI [4]
C0001175
UMLS CUI [5,1]
C0009566
UMLS CUI [5,2]
C0205082
UMLS CUI [6,1]
C0009566
UMLS CUI [6,2]
C0205318
UMLS CUI [7,1]
C0009450
UMLS CUI [7,2]
C1514873
UMLS CUI [7,3]
C1515119
UMLS CUI [8,1]
C0015967
UMLS CUI [8,2]
C0205318
UMLS CUI [9,1]
C0011849
UMLS CUI [9,2]
C0205318
UMLS CUI [10,1]
C0020538
UMLS CUI [10,2]
C0205318
UMLS CUI [11,1]
C0009566
UMLS CUI [11,2]
C0521102
UMLS CUI [11,3]
C0013216
10. patients with a history of drug allergy (≥ ctcae 2 level) such as shock or allergic symptoms, especially have allergic reactions to similar drugs in the past, have severe allergies reactions to drugs containing polysorbate eighty (tween 80);
Description

Drug Allergy CTCAE Grades | Shock | Allergic symptom | Allergic Reaction Pharmaceutical Preparations Similar | Severe allergy Pharmaceutical Preparations Containing Polysorbate 80 | Severe allergy Pharmaceutical Preparations Containing Tween 80

Data type

boolean

Alias
UMLS CUI [1,1]
C0013182
UMLS CUI [1,2]
C1516728
UMLS CUI [2]
C0036974
UMLS CUI [3]
C0740903
UMLS CUI [4,1]
C1527304
UMLS CUI [4,2]
C0013227
UMLS CUI [4,3]
C2348205
UMLS CUI [5,1]
C2945656
UMLS CUI [5,2]
C0013227
UMLS CUI [5,3]
C0332256
UMLS CUI [5,4]
C0032601
UMLS CUI [6,1]
C2945656
UMLS CUI [6,2]
C0013227
UMLS CUI [6,3]
C0332256
UMLS CUI [6,4]
C0041417
11. uncontrolled seizures or loss of insight due to mental disorders;
Description

Seizures Uncontrolled | Impaired insight Due to Mental disorders

Data type

boolean

Alias
UMLS CUI [1,1]
C0036572
UMLS CUI [1,2]
C0205318
UMLS CUI [2,1]
C0233823
UMLS CUI [2,2]
C0678226
UMLS CUI [2,3]
C0004936
12. pregnant or lactating women；
Description

Pregnancy | Breast Feeding

Data type

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
13. researchers think improper for this trial
Description

Study Subject Participation Status Inappropriate

Data type

boolean

Alias
UMLS CUI [1,1]
C2348568
UMLS CUI [1,2]
C1548788
Back to the top of the page

Similar models

Eligibility Breast Cancer NCT01939054

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Triple Negative Breast Neoplasm Recurrent Immunohistochemistry | Triple Negative Breast Neoplasm metastatic Immunohistochemistry
Item
1. histological and immunohistochemistry (ihc) confirmed recurrent or metastatic triple-negative breast cancer .
boolean
C3539878 (UMLS CUI [1,1])
C2945760 (UMLS CUI [1,2])
C0021044 (UMLS CUI [1,3])
C3539878 (UMLS CUI [2,1])
C1522484 (UMLS CUI [2,2])
C0021044 (UMLS CUI [2,3])
Prior Chemotherapy | Anthracyclines | taxane | Absence Prior Chemotherapy Post Neoplasm Metastasis
Item
2. previous chemotherapy should include anthracycline or taxane; no prior chemotherapy after metastasis.
boolean
C1514457 (UMLS CUI [1])
C0282564 (UMLS CUI [2])
C0215136 (UMLS CUI [3])
C0332197 (UMLS CUI [4,1])
C1514457 (UMLS CUI [4,2])
C0687676 (UMLS CUI [4,3])
C0027627 (UMLS CUI [4,4])
Gender | Age
Item
3. females with age between 18 and 70 years old
boolean
C0079399 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
ECOG performance status
Item
4. ecog performance status 0 or 1.
boolean
C1520224 (UMLS CUI [1])
Measurable Disease Quantity MRI | Measurable Disease Quantity CT | Target Lesion unresectable | Therapeutic radiology procedure Absent Target Lesion | Relapse Within Radiation Field
Item
5. at least one measurable disease according to the response evaluation criteria in solid tumor (recist) by magnetic resonance imaging, or computed tomography; the target lesions is unresectable; the target lesions did not receive radiotherapy or relapse within the radiation field;
boolean
C1513041 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0024485 (UMLS CUI [1,3])
C1513041 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
C0040405 (UMLS CUI [2,3])
C2986546 (UMLS CUI [3,1])
C1519810 (UMLS CUI [3,2])
C1522449 (UMLS CUI [4,1])
C0332197 (UMLS CUI [4,2])
C2986546 (UMLS CUI [4,3])
C0035020 (UMLS CUI [5,1])
C0332285 (UMLS CUI [5,2])
C1882536 (UMLS CUI [5,3])
Life Expectancy
Item
6. life expectancy ≥ 12 weeks.；
boolean
C0023671 (UMLS CUI [1])
White Blood Cell Count procedure | Neutrophil count | Platelet Count measurement | Hemoglobin measurement
Item
7. wbc count ≥ 4 × 109 / l, neutrophils ≥ 1.5 × 109 / l, platelet count ≥ 100 × 109 / l, hemoglobin ≥ 6.21mmol / l (10 g / dl);
boolean
C0023508 (UMLS CUI [1])
C0200633 (UMLS CUI [2])
C0032181 (UMLS CUI [3])
C0518015 (UMLS CUI [4])
Serum total bilirubin measurement | Aspartate aminotransferase measurement | Alanine aminotransferase measurement | Secondary malignant neoplasm of liver | Creatinine measurement, serum
Item
8. total bilirubin (tbl)≤ 1.5 x uln (upper limit of normal reference values); ast and alt ≤ 2.5 x uln or ≤ 5 uln (liver metastasis);serum creatinine ≤ 1.5 x uln.
boolean
C1278039 (UMLS CUI [1])
C0201899 (UMLS CUI [2])
C0201836 (UMLS CUI [3])
C0494165 (UMLS CUI [4])
C0201976 (UMLS CUI [5])
Toxicity Due to Prior Therapy | Patient recovered
Item
9. before enrollment, patients have fully recovered from previous treatment-related toxicity;
boolean
C0600688 (UMLS CUI [1,1])
C0678226 (UMLS CUI [1,2])
C1514463 (UMLS CUI [1,3])
C1115804 (UMLS CUI [2])
Fertility Contraceptive methods
Item
10. subjects with fertility must accept effective contraceptive measures;
boolean
C0015895 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
Informed Consent
Item
11. signed informed consent
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Prior Therapy | Anti-EGFR Monoclonal Antibody
Item
1. previously treatment regimen including anti egfr monoclonal antibody;
boolean
C1514463 (UMLS CUI [1])
C4522190 (UMLS CUI [2])
Pharmacotherapy Malignant Neoplasms
Item
2. receiving other anti-cancer medicine treatment during the study
boolean
C0013216 (UMLS CUI [1,1])
C0006826 (UMLS CUI [1,2])
Study Subject Participation Status
Item
3. participate in other clinical trials within 4 weeks in this group;
boolean
C2348568 (UMLS CUI [1])
taxane
Item
4. accepted taxane treatment in 1 year;
boolean
C0215136 (UMLS CUI [1])
Neurologic Symptoms Due to Metastatic malignant neoplasm to brain | Steroid therapy Edema
Item
5. presence of neurological symptoms due to brain metastasis, patients receiving steroidal anti-edema drugs therapy;
boolean
C0235031 (UMLS CUI [1,1])
C0678226 (UMLS CUI [1,2])
C0220650 (UMLS CUI [1,3])
C0149783 (UMLS CUI [2,1])
C0013604 (UMLS CUI [2,2])
Angina Pectoris Symptomatic Uncontrolled | Cardiac Arrhythmia Uncontrolled | Congestive heart failure Uncontrolled
Item
6. patients having a history of clinically significant symptomatic angina, arrhythmia or congestive heart failure without control;
boolean
C0002962 (UMLS CUI [1,1])
C0231220 (UMLS CUI [1,2])
C0205318 (UMLS CUI [1,3])
C0003811 (UMLS CUI [2,1])
C0205318 (UMLS CUI [2,2])
C0018802 (UMLS CUI [3,1])
C0205318 (UMLS CUI [3,2])
Interstitial Pneumonia Severe Chest CT | Pulmonary Fibrosis Severe Chest CT
Item
7. diagnosed with severe interstitial pneumonitis or pulmonary fibrosis by chest ct;
boolean
C0206061 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0202823 (UMLS CUI [1,3])
C0034069 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
C0202823 (UMLS CUI [2,3])
Pleural effusion disorder | Ascites Requirement Drainage
Item
8. pleural effusion, ascites require to be drained;
boolean
C0032227 (UMLS CUI [1])
C0003962 (UMLS CUI [2,1])
C1514873 (UMLS CUI [2,2])
C0013103 (UMLS CUI [2,3])
Drug Dependence | Drug abuse | Alcoholics Long-term | AIDS | Complications Severe | Complications Uncontrolled | Communicable Disease Requirement Systemic therapy | Fever Uncontrolled | Diabetes Mellitus Uncontrolled | Hypertensive disease Uncontrolled | Complications Interfere with Pharmacotherapy
Item
9. adverse drug addiction and drug abuse, long-term alcoholics, as well as aids patients; patients with severe or uncontrolled complications, such as infection requiring systemic therapy, fever (≥ 38 ℃), diabetes or hypertension can not be controlled by medicine, other complications may interfere with drug therapy;
boolean
C1510472 (UMLS CUI [1])
C0013146 (UMLS CUI [2])
C0687725 (UMLS CUI [3,1])
C0443252 (UMLS CUI [3,2])
C0001175 (UMLS CUI [4])
C0009566 (UMLS CUI [5,1])
C0205082 (UMLS CUI [5,2])
C0009566 (UMLS CUI [6,1])
C0205318 (UMLS CUI [6,2])
C0009450 (UMLS CUI [7,1])
C1514873 (UMLS CUI [7,2])
C1515119 (UMLS CUI [7,3])
C0015967 (UMLS CUI [8,1])
C0205318 (UMLS CUI [8,2])
C0011849 (UMLS CUI [9,1])
C0205318 (UMLS CUI [9,2])
C0020538 (UMLS CUI [10,1])
C0205318 (UMLS CUI [10,2])
C0009566 (UMLS CUI [11,1])
C0521102 (UMLS CUI [11,2])
C0013216 (UMLS CUI [11,3])
Drug Allergy CTCAE Grades | Shock | Allergic symptom | Allergic Reaction Pharmaceutical Preparations Similar | Severe allergy Pharmaceutical Preparations Containing Polysorbate 80 | Severe allergy Pharmaceutical Preparations Containing Tween 80
Item
10. patients with a history of drug allergy (≥ ctcae 2 level) such as shock or allergic symptoms, especially have allergic reactions to similar drugs in the past, have severe allergies reactions to drugs containing polysorbate eighty (tween 80);
boolean
C0013182 (UMLS CUI [1,1])
C1516728 (UMLS CUI [1,2])
C0036974 (UMLS CUI [2])
C0740903 (UMLS CUI [3])
C1527304 (UMLS CUI [4,1])
C0013227 (UMLS CUI [4,2])
C2348205 (UMLS CUI [4,3])
C2945656 (UMLS CUI [5,1])
C0013227 (UMLS CUI [5,2])
C0332256 (UMLS CUI [5,3])
C0032601 (UMLS CUI [5,4])
C2945656 (UMLS CUI [6,1])
C0013227 (UMLS CUI [6,2])
C0332256 (UMLS CUI [6,3])
C0041417 (UMLS CUI [6,4])
Seizures Uncontrolled | Impaired insight Due to Mental disorders
Item
11. uncontrolled seizures or loss of insight due to mental disorders;
boolean
C0036572 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
C0233823 (UMLS CUI [2,1])
C0678226 (UMLS CUI [2,2])
C0004936 (UMLS CUI [2,3])
Pregnancy | Breast Feeding
Item
12. pregnant or lactating women；
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Study Subject Participation Status Inappropriate
Item
13. researchers think improper for this trial
boolean
C2348568 (UMLS CUI [1,1])
C1548788 (UMLS CUI [1,2])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial